Physician
Amde, Wendewessen
Amde, Wendewessen was paid $2.65M by Medicaid between Jan 2018 and Dec 2024, across 17 billing codes. Its largest line is J0178, Injection, aflibercept, 1 mg — 59% of everything it billed.
33Billing provider infoAMDE, WENDEWESSEN
CHICAGO, IL 60601
CHICAGO, IL 60601
33aNPI1386837474assigned 08/22/2007
33bProvider typeOphthalmology Physician
28Total paid$2.65M
24GClaims24,298
24DCodes billed17
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Ophthalmology Physician providers in Illinois
Rank by total paid#2 of 431
Median peer was paid$34K
This provider vs. median78×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,523 | $65K | |
| 2019 | 4,017 | $243K | |
| 2020 | 3,790 | $407K | |
| 2021 | 3,272 | $323K | |
| 2022 | 3,795 | $628K | |
| 2023 | 4,024 | $752K | |
| 2024incomplete | 2,877 | $234K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 59% | 1,241 | 959 | $1.57M |
| 67028 | Intravitreal injection of a pharmacologic agent | 16% | 2,432 | 2,016 | $416K |
| 67228 | 6.6% | 540 | 440 | $174K | |
| 92134 | 6.4% | 9,037 | 7,918 | $169K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 2.8% | 2,396 | 1,961 | $75K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.3% | 1,532 | 1,436 | $62K |
| 92226 | 2.3% | 2,357 | 1,341 | $62K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.0% | 2,171 | 2,041 | $54K |
| J9035 | Injection, bevacizumab, 10 mg | 1.2% | 577 | 483 | $33K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 662 | 548 | $11K |
| 92225 | <1% | 359 | 199 | $9K | |
| 92201 | <1% | 511 | 404 | $5K |
5 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.